18 (51%) |
Antibody |
[16,17,20,21,22,23,25,26,27,28,31,33,36,39,40,42,45,48] |
12 (34%) |
T cell count |
[16,20,21,26,27,28,30,32,36,38,42,47] |
12 (34%) |
CD8+ T cell count |
[19,22,24,32,34,35,36,38,39,48,49,50] |
11 (31%) |
Virus Neutralisation Titre |
[22,25,27,29,30,34,36,37,43,44,46] |
4 (12%) |
CD4+ T cell count |
[19,32,35,38] |
3 (9%) |
CD8+ T Cell, IFN-y+ Percentage |
[19,21,41] |
3 (9%) |
CD4+ T Cell, IFN-y+ Percentage |
[19,21] |
2 (6%) |
CD4+ T Cell, TNF-a+ Percentage |
[19,21] |
2 (6%) |
CD8+ T Cell, TNF-a+ Percentage |
[21] |
2 (6%) |
CD4+ T Cell, IL-2+ Percentage |
[19,21] |
2 (6%) |
CD8+ T Cell, Il-2+ Percentage |
[21] |
1 (3%) |
CD4+ T Cell, Il-17+ Percentage |
[19] |